Hypoglycemic agent
    3.
    发明公开
    Hypoglycemic agent 失效
    低血糖过敏

    公开(公告)号:EP0196222A2

    公开(公告)日:1986-10-01

    申请号:EP86302217.4

    申请日:1986-03-26

    摘要: A compound of D-phenylalanine derivative for hypoglycemic use, represented by the general formula
    wherein R 1 is selected from hydrogen, alkyl of 1 to 5 carbon atoms, aryl of 6 to 12 carbon atoms, aralkyl of 6 to 12 carbon
    and -CH 2 -OCO-C(CH 3 ) 3 ; R 2 is selected from groups comprising aryl of 6 to 12 carbon atoms, a hetero six-membered ring, a hetero five-membered ring, cycloalkyl, or cycloalkenyl, any of which groups may have one or more substituents; and R 3 is selected from hydrogen and alkyl of 1 to 5 carbon atoms; the salts thereof, and precursors which can be converted thereto in the human or animal body.
    Some of the compounds are novel per se.

    摘要翻译: 用于降血糖用途的D-苯丙氨酸衍生物的化合物,由通式R 1表示,选自氢,1至5个碳原子的烷基,6至12个碳原子的芳基,6至12个碳原子的芳烷基, 图像> -CH 2 CO 2 R 3,-CH(CH 3)-OCO-R 3和-CH 2 -OCO-C(CH 3)3; R 2选自包含6至12个碳原子的芳基,杂六元环,杂五元环,环烷基或环烯基,其中任何基团可以具有一个或多个取代基; 并且R 3选自氢和1至5个碳原子的烷基; 其盐,以及可在人或动物体内转化为其的前体。 一些化合物本身是新颖的。

    Pharmaceutical composition
    4.
    发明公开
    Pharmaceutical composition 失效
    Pharmazeutische Zusammensetzung。

    公开(公告)号:EP0093551A2

    公开(公告)日:1983-11-09

    申请号:EP83302290.8

    申请日:1983-04-22

    摘要: Phenylalinine derivatives having the general formula:
    and their non-toxic salts, have been found to promote the absorption of medicinal substances such as insulin. In the above formula, R' is a hydrogen atom, a fluorine atom, a nitro group, a hydroxyl group or a hydroxyl group protected by an esterifying group, X is -CO- or -SO 2 -, -Y- is a straight bond, a lower alkylene group, a substituted or unsubstituted vinylene group, or a group having the form- fula -CH 2 -O- or -0-CH 2 -, and R 2 is a substituted or unsubstituted phenyl or naphthyl group; or the group R 2 -Y-CO- is an N-benzyloxy-carbonylphenylalanyl group, an N-benzyloxycarbonyl-4-flurophenylalanyl group or an N-(m-methoxycinnamoyl)phenylalanyl group.

    摘要翻译: 已经发现具有以下通式的苯基亚胺衍生物:... ...及其无毒盐促进药物作为胰岛素的吸收。 在上式中,R 1是氢原子,氟原子,硝基,羟基或被酯化基保护的羟基,X是-CO-或-SO 2 - , - Y-是 直链,低级亚烷基,取代或未取代的亚乙烯基,或具有形式的-CH 2 -O-或-O-CH 2 - 的基团,R 2为取代或未取代的苯基或萘基; 或基团R 2 -Y-CO-是N-苄氧基羰基苯丙氨酰基,N-苄氧羰基-4-氟苯丙氨酰基或N-(间甲氧基肉桂酰基)苯丙氨酰基。

    Pharmaceutical composition
    6.
    发明公开
    Pharmaceutical composition 失效
    药物组合物

    公开(公告)号:EP0093551A3

    公开(公告)日:1985-11-21

    申请号:EP83302290

    申请日:1983-04-22

    摘要: Phenylalinine derivatives having the general formula:
    and their non-toxic salts, have been found to promote the absorption of medicinal substances such as insulin. In the above formula, R' is a hydrogen atom, a fluorine atom, a nitro group, a hydroxyl group or a hydroxyl group protected by an esterifying group, X is -CO- or -SO 2 -, -Y- is a straight bond, a lower alkylene group, a substituted or unsubstituted vinylene group, or a group having the form- fula -CH 2 -O- or -0-CH 2 -, and R 2 is a substituted or unsubstituted phenyl or naphthyl group; or the group R 2 -Y-CO- is an N-benzyloxy-carbonylphenylalanyl group, an N-benzyloxycarbonyl-4-flurophenylalanyl group or an N-(m-methoxycinnamoyl)phenylalanyl group.

    摘要翻译: 具有通式的苯丙氨酸衍生物及其无毒盐已被发现可促进药物如胰岛素的吸收。 在上式中,R'是由酯化基团保护的氢原子,氟原子,硝基,羟基或羟基,X是-CO-或-SO 2 - , - Y-是直键 低级亚烷基,取代或未取代的亚乙烯基或具有-CH2-O-或-O-CH2-的基团,R2是取代或未取代的苯基或萘基; 或基团R2-Y-CO-是N-苄氧羰基苯丙氨酰基,N-苄氧羰基-4-氟苯丙氨酰基或N-(间甲氧基肉桂酰)苯丙氨酰基。